Multiple myeloma is a complex and severe blood malignancy that affects plasma cells in the bone marrow. These abnormal cells multiply uncontrollably, impairing the immune system, damaging bones, and affecting vital organs such as the kidneys.
India has become one of the top destinations for multiple myeloma treatment due to its cutting-edge technology, internationally trained oncologists, high-quality care, and affordable packages. From precise diagnosis to cutting-edge procedures such as immunotherapy and stem cell transplant, India offers a comprehensive approach to managing this medical condition.
Cost-effective care: Treatment costs 60–80% less than in Western countries
Experienced oncologists: Internationally trained, with specialization in hematologic malignancies
Advanced technologies: Including PET-CT, FISH, bone marrow biopsy, and CAR T-cell therapy (in select centers)
Multidisciplinary teams: Hematologists, medical oncologists, radiation oncologists, and transplant specialists
Comprehensive services: Including diagnostics, treatment, supportive care, and rehabilitation
Multiple myeloma is a cancer of plasma cells, a type of white blood cell found in the bone marrow. These cells normally produce antibodies to fight infections. In multiple myeloma, abnormal plasma cells produce excessive monoclonal proteins that crowd out healthy cells and damage various organs.
Smoldering Multiple Myeloma (SMM): Asymptomatic but abnormal protein levels present.
Active Multiple Myeloma: Symptomatic with signs like bone pain, anaemia, and kidney dysfunction.
Light Chain Myeloma: Produces only light chains, leading to kidney damage.
Non-Secretory Myeloma: Rare type without detectable monoclonal proteins in blood or urine.
Plasma Cell Leukemia: A more aggressive and rare form with plasma cells in the blood.
You may be a candidate for multiple myeloma treatment if you:
Have confirmed diagnosis through blood, urine, and bone marrow tests
Experience symptoms such as bone pain, fatigue, or recurrent infections
Have measurable levels of M-protein or free light chains
Are in overall good health to tolerate chemotherapy or stem cell transplant
Early detection significantly improves treatment outcomes. A thorough evaluation by an oncologist is essential for determining the best treatment plan.
Used to kill rapidly dividing myeloma cells. Common drugs include melphalan, cyclophosphamide, and bortezomib.
Targets specific proteins in cancer cells. Examples: bortezomib, carfilzomib, ixazomib.
Boosts the immune system to fight cancer. Examples: daratumumab, elotuzumab, lenalidomide.
Autologous (patient’s own cells) or allogeneic (donor cells) transplants help restore healthy bone marrow after high-dose chemotherapy.
Used to treat bone lesions or spinal compression.
Includes bisphosphonates for bone strength, blood transfusions, antibiotics, and medications to reduce calcium levels and protect kidneys.
We believe that great care starts with trust. That’s why we ensure complete transparency in our treatment pricing—no surprises, no hidden fees, just honest and clear costs for the care you deserve.
| Type of Multiple Myeloma Treatment Treatment | Estimated Cost (USD) |
|---|---|
Chemotherapy (per cycle) Chemotherapy remains a cornerstone treatment for multiple myeloma, utilizing cytotoxic drugs to destroy malignant plasma cells or inhibit their proliferation. Typically administered in combination with other therapies, it serves as both induction therapy and for disease control in relapsed/refractory cases. | $600 – $1,200 |
Targeted Therapy (per cycle) This systemic treatment uses cytotoxic drugs to target and destroy rapidly dividing myeloma cells throughout the body. While newer therapies have emerged, chemotherapy remains fundamental in induction regimens, stem cell transplant preparation, and palliative care for symptomatic disease. | $2,000 – $4,000 |
Immunotherapy (per cycle) This innovative treatment approach harnesses and enhances the body’s immune system to specifically target and eliminate malignant plasma cells. Immunotherapy has revolutionized myeloma care, offering precision targeting with reduced off-tumor toxicity compared to conventional chemotherapy. | $3,000 – $6,000 |
Autologous Stem Cell Transplant Autologous Stem Cell Treatment remains a cornerstone treatment for eligible myeloma patients, offering deeper remission and prolonged survival when combined with high-dose chemotherapy. | $13,000 – $18,000 |
Radiation Therapy (per session) This precision medicine approach uses specialized drugs to disrupt specific molecular pathways critical for myeloma cell survival and proliferation, offering enhanced efficacy with reduced systemic toxicity compared to traditional chemotherapy. | $150 – $300 |
Supportive Medications (monthly) This essential component of myeloma management focuses on preventing and managing complications while improving quality of life. Tailored to individual needs, it works synergistically with disease-directed therapies. | $300 – $800 |
Note: Final costs depend on disease stage, treatment duration, drugs used, hospital stay, and individual patient factors.
Lab tests and pathology
Infusion and hospital care
Oncologist consultations
Medications and chemotherapy drugs
Post-treatment monitoring and discharge planning
Airport pickup and drop
International & domestic travel
Hotel and accommodation outside hospital
Complications requiring ICU care or re-hospitalization
Post-operative physiotherapy or psychiatric care
Management of complications or unrelated conditions
Donor search for allogeneic transplant (if applicable)
Complete Blood Count (CBC)
Serum Protein Electrophoresis (SPEP)
Free Light Chain Assay
Urine Protein Electrophoresis (UPEP)
Bone Marrow Biopsy
MRI, CT, PET-CT scans
Cytogenetic & FISH analysis
India has emerged as a global leader in Multiple Myeloma Treatment due to several key advantages:
Affordable treatment without compromising quality
Access to FDA-approved therapies and advanced labs
Highly experienced oncologists and haematologists
State-of-the-art hospitals in Delhi, Mumbai, Chennai, and Hyderabad
Multilingual support for international patients
Fast-track medical visa and coordinated travel assistance by HOSPISITY
🩺 Trusted Medical Travel Partner – End-to-end patient support
👨⚕️ Access to Top Cancer Centres – Handpicked specialists in Multiple Myeloma Treatment
🏥 Global Hospital Network – Leading hospitals in India and Turkey
💬 Personalized Case Handling – Dedicated HRE (Hospisity Relationship Executive)
📞 Free teleconsultation before arrival and post-treatment follow-up
It is not curable in most cases but can be managed effectively with treatment. Many patients live in long-term remission.
Success rates vary by stage and response, but many patients experience improved quality of life and extended survival.
Treatment can last several months, depending on the protocol (chemotherapy cycles, stem cell transplant, etc.).
Some CAR T-cells persist as memory cells, potentially offering long-term immunity.
Yes. HOSPISITY offers complete assistance including visas, appointments, hospital coordination, and accommodation.
Top JCI Accredited Hospitals centers in Delhi, Mumbai, Chennai, Hyderabad, and Bangalore offer Multiple Myeloma Treatment,
Director - Medical Oncology, Hematology, BMT & Cellular Therapy
Apollo Proton Cancer Centre,Chennai
Oncology | Medical Oncology
35+ Years Experience
Head of the Department & Senior Consultant Medical Oncology
Shalby Sanar International Hospital
Oncology | Medical Oncology
10+ Years Experience
Director - Haemato-oncology and Bone Marrow Transplant
BLK-Max Super Speciality Hospital,Delhi
Haematology | Haemato-Oncology| Bone Marrow Transplant
18+ Years Experience
Principal Director & Chief - Hematology, Hemato Oncology & Bone Marrow Transplant
Fortis Memorial Research Institute,Gurugram
Haematology | Haemato-Oncology| Bone Marrow Transplant
15+ Years Experience
We believe that great care starts with trust. That’s why we ensure complete transparency in our treatment pricing—no surprises, no hidden fees, just honest and clear costs for the care you deserve.
